Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study (Q33590407)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study |
scientific article |
Statements
1 reference
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study (English)
1 reference
Hao Hu
1 reference
Zhenhua Duan
1 reference
Xiaoran Long
1 reference
Yancu Hertzanu
1 reference
Haibin Shi
1 reference
Sheng Liu
1 reference
Zhengqiang Yang
1 reference
9 May 2014
1 reference
1 reference
e96620
1 reference
1 reference
1 reference
1 reference
2 references
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference